117 related articles for article (PubMed ID: 26642877)
1. Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis.
Mongula JE; Slangen BF; Lambregts DM; Cellini F; Bakers FC; Lutgens LC; Van Gorp T; Kruse AJ; Kruitwagen RF; Beets-Tan RG
Radiat Oncol; 2015 Dec; 10():252. PubMed ID: 26642877
[TBL] [Abstract][Full Text] [Related]
2. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of magnetic resonance imaging in patients with cervical cancer after brachytherapy: a meta-analysis.
Zhang J; Tian W; Bu X; Wang X; Tian F; Wu L
Acta Radiol; 2019 May; 60(5):670-676. PubMed ID: 30149749
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
6. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
7. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results.
Beriwal S; Kannan N; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):685-90. PubMed ID: 21908180
[TBL] [Abstract][Full Text] [Related]
9. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
10. Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.
Mayr NA; Wang JZ; Lo SS; Zhang D; Grecula JC; Lu L; Montebello JF; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):719-27. PubMed ID: 19632061
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
12. Change in T2-fat saturation MRI correlates with outcome in cervical cancer patients.
Ma DJ; Zhu JM; Grigsby PW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e707-12. PubMed ID: 21641733
[TBL] [Abstract][Full Text] [Related]
13. Predicting the necessity of adding catheters to intracavitary brachytherapy for women undergoing definitive chemoradiation for locally advanced cervical cancer.
Palhares DMF; Marconi DG; Azevedo TL; Hess CB; Fregnani JHTG; Affonso RJ; Veneziani ACLC; Canton HP; Gadia R; Spadim MD; Rossini RR; Kamrava M
Brachytherapy; 2018; 17(6):935-943. PubMed ID: 30100273
[TBL] [Abstract][Full Text] [Related]
14. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
[TBL] [Abstract][Full Text] [Related]
15. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.
Mayr NA; Taoka T; Yuh WT; Denning LM; Zhen WK; Paulino AC; Gaston RC; Sorosky JI; Meeks SL; Walker JL; Mannel RS; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):14-22. PubMed ID: 11777618
[TBL] [Abstract][Full Text] [Related]
16. Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging.
Federico M; Hernandez-Socorro CR; Ribeiro I; Martin JG; Oramas MDR; Saez-Bravo ML; Jimenez PCL
Radiat Oncol; 2019 Oct; 14(1):173. PubMed ID: 31585543
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI.
Nam H; Park W; Huh SJ; Bae DS; Kim BG; Lee JH; Lee JW; Lim DH; Han Y; Park HC; Ahn YC
Gynecol Oncol; 2007 Nov; 107(2):320-5. PubMed ID: 17675222
[TBL] [Abstract][Full Text] [Related]
18. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
20. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
